RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment

Patent ExpiryapprovedRenovoCath®Positive

AI Analysis

Summary

RenovoRx received a Notice of Allowance for a new U.S. patent covering its RenovoCath® dual-occlusion catheter designed for targeted drug delivery in cancer treatment.

Outcome Details

Notice of Allowance received for U.S. patent covering RenovoCath® dual-occlusion catheter for targeted therapeutic drug-delivery

Importance:4/10

Sentiment:

0.60

patentmedical devicedrug deliveryoncology

Related Companies

$RNXT

Read the original article

Published by yahoo_finance on August 20, 2026 12:30 PM

Read Original